The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to beta-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment

[1]  M. Tominaga,et al.  TRPM2, a Susceptibility Gene for Bipolar Disorder, Regulates Glycogen Synthase Kinase-3 Activity in the Brain , 2015, The Journal of Neuroscience.

[2]  L. Tan,et al.  Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease , 2014, Neuropsychopharmacology.

[3]  F. LaFerla,et al.  Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease , 2014, Neurobiology of Disease.

[4]  C. Iadecola,et al.  The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.

[5]  F. Schmitt,et al.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..

[6]  C. Hetz,et al.  Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases , 2014, Nature Reviews Neuroscience.

[7]  A. Palotás,et al.  Impaired electro-genesis in skeletal muscle fibers of transgenic Alzheimer mice , 2014, Neurochemistry International.

[8]  V. Martins,et al.  Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease , 2013, Journal of neurochemistry.

[9]  Y. Mori,et al.  Modulation of NMDAR Subunit Expression by TRPM2 Channels Regulates Neuronal Vulnerability to Ischemic Cell Death , 2013, The Journal of Neuroscience.

[10]  J. Pozueta,et al.  Synaptic changes in Alzheimer’s disease and its models , 2013, Neuroscience.

[11]  J. Macdonald,et al.  The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity , 2013, The Journal of Neuroscience.

[12]  W. Klein,et al.  Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers , 2013, The Journal of Neuroscience.

[13]  L. Schmued,et al.  Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's Disease model , 2013, Behavioural Brain Research.

[14]  A. Perraud,et al.  The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation , 2013, Immunologic research.

[15]  P. Herson,et al.  TRPM2 channel activation following in vitro ischemia contributes to male hippocampal cell death , 2012, Neuroscience Letters.

[16]  I. Izquierdo,et al.  Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation , 2012, Proceedings of the National Academy of Sciences.

[17]  C. Hetz,et al.  Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applications , 2012, FEBS letters.

[18]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[19]  R. Malinow.  New developments on the role of NMDA receptors in Alzheimer's disease , 2012, Current Opinion in Neurobiology.

[20]  J. Macdonald,et al.  Loss of glutathione homeostasis associated with neuronal senescence facilitates TRPM2 channel activation in cultured hippocampal pyramidal neurons , 2012, Molecular Brain.

[21]  J. Macdonald,et al.  Dependence of NMDA/GSK-3β Mediated Metaplasticity on TRPM2 Channels at Hippocampal CA3-CA1 Synapses , 2011, Molecular Brain.

[22]  Ravi S. Menon,et al.  Elimination of the Vesicular Acetylcholine Transporter in the Striatum Reveals Regulation of Behaviour by Cholinergic-Glutamatergic Co-Transmission , 2011, PLoS biology.

[23]  M. Grafe,et al.  Sex Differences in Neuroprotection Provided by Inhibition of TRPM2 Channels following Experimental Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  A. Palotás,et al.  Extraneuronal toxicity of Alzheimer's β‐amyloid peptide: Comparative study on vertebrate skeletal muscles , 2011, Muscle & nerve.

[25]  Shaomin Li,et al.  Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.

[26]  Fabiana A. Caetano,et al.  Amyloid‐beta oligomers increase the localization of prion protein at the cell surface , 2011, Journal of neurochemistry.

[27]  C. Hetz,et al.  Protein folding stress in neurodegenerative diseases: a glimpse into the ER. , 2011, Current opinion in cell biology.

[28]  M. Caron,et al.  Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior , 2011, PloS one.

[29]  M. Verbeek,et al.  Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels , 2010, Neurobiology of Disease.

[30]  W. Engel,et al.  Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers , 2010, Acta Neuropathologica.

[31]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[32]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[33]  Ian Parker,et al.  Calcium Signaling and Amyloid Toxicity in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[34]  J. Lipski,et al.  Differential expression of TRPM2 and TRPV4 channels and their potential role in oxidative stress-induced cell death in organotypic hippocampal culture. , 2010, Neurotoxicology.

[35]  R. Kraft,et al.  Transient Receptor Potential Melastatin 2 Is Required for Lipopolysaccharide-Induced Cytokine Production in Human Monocytes , 2010, The Journal of Immunology.

[36]  T. O'Leary,et al.  Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease , 2009, Behavioural Brain Research.

[37]  H. Vinters,et al.  β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.

[38]  J. Xie,et al.  Intracellular calcium activates TRPM2 and its alternative spliced isoforms , 2009, Proceedings of the National Academy of Sciences.

[39]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[40]  Philippe Pierre,et al.  SUnSET, a nonradioactive method to monitor protein synthesis , 2009, Nature Methods.

[41]  J. Macdonald,et al.  Ca2+‐dependent induction of TRPM2 currents in hippocampal neurons , 2009, The Journal of physiology.

[42]  F. Tempia,et al.  Selection of Reference Genes for Quantitative Real-time RT-PCR Studies in Mouse Brain , 2009, Journal of Molecular Neuroscience.

[43]  Meredith C. Hermosura,et al.  Altered functional properties of a TRPM2 variant in Guamanian ALS and PD , 2008, Proceedings of the National Academy of Sciences.

[44]  M. Block,et al.  Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model , 2008, The Journal of Neuroscience.

[45]  R. Penner,et al.  TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration , 2008, Nature Medicine.

[46]  W. Paschen,et al.  Endoplasmic Reticulum Stress , 2007, Annals of the New York Academy of Sciences.

[47]  W. Klein,et al.  Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.

[48]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[49]  J. Cheung,et al.  Regulation of the Transient Receptor Potential Channel TRPM2 by the Ca2+ Sensor Calmodulin* , 2006, Journal of Biological Chemistry.

[50]  R. McIntyre,et al.  Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[51]  P. Murdock,et al.  TRPM2 Is Elevated in the tMCAO Stroke Model, Transcriptionally Regulated, and Functionally Expressed in C13 Microglia , 2006, Journal of receptor and signal transduction research.

[52]  M. Ohno,et al.  Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 , 2006, The European journal of neuroscience.

[53]  P. Murdock,et al.  Tissue Distribution Profiles of the Human TRPM Cation Channel Family , 2006, Journal of receptor and signal transduction research.

[54]  C. D. Benham,et al.  Amyloid β‐peptide(1–42) and hydrogen peroxide‐induced toxicity are mediated by TRPM2 in rat primary striatal cultures , 2005, Journal of neurochemistry.

[55]  D. Borchelt,et al.  Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities , 2005, Neurobiology of Disease.

[56]  B. Stoddard,et al.  Accumulation of Free ADP-ribose from Mitochondria Mediates Oxidative Stress-induced Gating of TRPM2 Cation Channels* , 2005, Journal of Biological Chemistry.

[57]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[58]  J. Macdonald,et al.  A Key Role for TRPM7 Channels in Anoxic Neuronal Death , 2003, Cell.

[59]  D. Borchelt,et al.  Environmental Enrichment Exacerbates Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease , 2003, Journal of neuropathology and experimental neurology.

[60]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[61]  T. Kudo,et al.  FAD-linked presenilin-1 mutants impede translation regulation under ER stress. , 2002, Biochemical and biophysical research communications.

[62]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[63]  A. Perraud,et al.  ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology , 2001, Nature.

[64]  C. Ikonomidou,et al.  Neuronal death enhanced by N-methyl-D-aspartate antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C. Culmsee,et al.  Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.

[66]  Tamara Hershey,et al.  Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis , 1999, Neuropsychopharmacology.

[67]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Premkumar,et al.  Cellular aspects of the inflammatory response in Alzheimer's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[69]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[70]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[71]  H. Soininen,et al.  Clinical symptoms and symptom signatures of Alzheimer's disease subgroups. , 2013, Journal of Alzheimer's disease : JAD.

[72]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[73]  W. Klein,et al.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[75]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.

[76]  G. Schultz,et al.  Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. , 2004, American journal of physiology. Cell physiology.

[77]  C. Finch,et al.  Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[78]  K. Dikranian,et al.  Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity , 2002, Molecular Psychiatry.

[79]  T. Rammsayer,et al.  Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. , 2001, Learning & memory.

[80]  R. L. Russell,et al.  Protein disulfide isomerase in Alzheimer disease. , 2000, Antioxidants & redox signaling.

[81]  T. Beach,et al.  Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. , 2000, The American journal of pathology.

[82]  P. A. Peterson,et al.  beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. , 2000, The Journal of biological chemistry.

[83]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.